Methods of treating obsessive compulsive disorder (OCD) or anxiety using an antibody that binds to annexin-1

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10752677
APP PUB NO 20150004164A1
SERIAL NO

14365311

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a specific binding molecule that binds to Annexin-1 (Anx-A1) for use in the treatment of obsessive compulsive disorder (OCD) or a disease related to OCD. The invention also provides a pharmaceutical composition comprising a specific binding molecule of the invention for use in the treatment of obsessive compulsive disorder (OCD) or a disease related to OCD.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDANNEX LIMITED1 LOCHRIN SQUARE 92-98 FOUNTAINBRIDGE EDINBURGH EH3 9QA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
D'Acquisto, Fulvio London, GB 7 7
Perretti, Mauro London, GB 11 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 25, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 25, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00